House Bioeconomic Development Study Committee
Substitute HB 1095
The Georgia Innovation Center Act, a comprehensive life sciences economic development strategy, is being considered by the Georgia House.
The Georgia Science Education and Employment Development Act is a companion bill to HB 1095. HB 1188 is a tax incentive bill to spur expansion and development of the life sciences industry in Georgia.
The House Resolution salutes Georgia Bio and welcomes the 2009 Biotechnology Industry Organization International Convention to Atlanta.
House Resolution 662, adopted April 20, 2007, established the House Georgia Bioeconomic Development Study Committee. The committee is composed of four House members and three life sciences industry representatives. The members are:
- Rep. Charlice Byrd (R-20th District) -- Chair
- Rep. Karla Drenner (D-86th District)
- Rep. Carl Rogers (R-26th District)
- Rep. Larry O’Neal (R-146th District)
- Clifton A. Baile, Ph.D., Professor, University of Georgia
- Fabrice Egros, Ph.D., MBA, President, UCB Inc.
- Russell M. Medford, M.D., Ph.D., President & CEO, AtheroGenics Inc.
The committee will seek to develop sound principles and public policy to guide the State of Georgia in designing a comprehensive life sciences economic development strategy.
The committee’s final report will identify existing strengths and weaknesses and will suggest how to utilize current resources and expertise within state government more efficiently. It will suggest legislation that will serve as a road map for creating, retaining and recruiting life sciences companies, moving Georgia into a 21st century bioeconomy.
Four, full-day hearings were held, followed by a summit in early December to adopt the final report and propose legislation for the 2008 session of the General Assembly. The hearings focused on the roles of industry, government, universities and public education system in supporting life sciences economic development.